The P2X7 receptor in inflammatory diseases: angel or demon?

LEB Savio, P de Andrade Mello… - Frontiers in …, 2018 - frontiersin.org
Under physiological conditions, adenosine triphosphate (ATP) is present at low levels in the
extracellular milieu, being massively released by stressed or dying cells. Once outside the …

P2X7 in cancer: from molecular mechanisms to therapeutics

R Lara, E Adinolfi, CA Harwood, M Philpott… - Frontiers in …, 2020 - frontiersin.org
P2X7 is a transmembrane receptor expressed in multiple cell types including neurons,
dendritic cells, macrophages, monocytes, B and T cells where it can drive a wide range of …

Multifaceted effects of extracellular adenosine triphosphate and adenosine in the tumor–host interaction and therapeutic perspectives

P de Andrade Mello, R Coutinho-Silva… - Frontiers in …, 2017 - frontiersin.org
Cancer is still one of the world's most pressing health-care challenges, leading to a high
number of deaths worldwide. Immunotherapy is a new developing therapy that boosts …

P2X7 receptor: a critical regulator and potential target for breast cancer

X Zhu, Q Li, W Song, X Peng, R Zhao - Journal of Molecular Medicine, 2021 - Springer
Breast cancer is currently the most common cancer and the leading cause of cancer death
among women worldwide. Advanced breast cancer is prone to metastasis, and there is …

ATP ion channel P2X7 receptor as a regulatory molecule in the progression of colorectal cancer

C Zuo, Y Xu, P He, W Zhang - European Journal of Medicinal Chemistry, 2023 - Elsevier
Large amounts of adenosine triphosphate (ATP), a natural P2X7 receptor activator, are
released during colorectal carcinogenesis. P2X7 receptor activation regulates the activity of …

[HTML][HTML] Effect of P2X7 receptor on tumorigenesis and its pharmacological properties

W Zhang, C Hu, Z Zhu, H Luo - Biomedicine & Pharmacotherapy, 2020 - Elsevier
The occurrence and development of tumors is a multi-factor, multi-step, multi-gene
pathological process, and its treatment has been the most difficult problem in the field of …

Role of the P2X7 receptor in tumor-associated inflammation

E Adinolfi, E De Marchi, E Orioli, A Pegoraro… - Current Opinion in …, 2019 - Elsevier
Highlights•Tumor bearing P2X7R null mice show increased and better performing
Treg.•Chemotactic gradient established by P2X7R ligands favors tumor infiltration by …

Alternative splicing of P2RX7 pre-messenger RNA in health and diseases: Myth or reality?

J Benzaquen, S Heeke, SJ dit Hreich, L Douguet… - biomedical …, 2019 - Elsevier
Alternative splicing (AS) tremendously increases the use of genetic information by
generating protein isoforms that differ in protein–protein interactions, catalytic activity and/or …

P2RX7 promotes osteosarcoma progression and glucose metabolism by enhancing c-Myc stabilization

G Sheng, Y Gao, Q Ding, R Zhang, T Wang… - Journal of Translational …, 2023 - Springer
Background Osteosarcoma is the most common malignant tumor in bone and its prognosis
has reached a plateau in the past few decades. Recently, metabolic reprogramming has …

Autocrine and paracrine purinergic signaling in the most lethal types of cancer

M Reyna-Jeldes, M Díaz-Muñoz, JA Madariaga… - Purinergic …, 2021 - Springer
Cancer comprises a collection of diseases that occur in almost any tissue and it is
characterized by an abnormal and uncontrolled cell growth that results in tumor formation …